Abstract:Lung cancer is a significant cause of cancer-related death worldwide. It can be broadly categorised into small-cell lung cancer (SCLC) and Non-small cell lung cancer (NSCLC). Surgical intervention, radiation therapy, and the administration of chemotherapeutic medications are among the current treatment modalities. However, the application of chemotherapy may be limited in more advanced stages of metastasis due to the potential for adverse effects and a lack of cell selectivity. Although small-molecule anticancer treatments have demonstrated effectiveness, they still face several challenges. The challenges at hand in this context comprise insufficient solubility in water, limited bioavailability at specific sites, adverse effects, and the requirement for epidermal growth factor receptor inhibitors that are genetically tailored. Bio-macromolecular drugs, including small interfering RNA (siRNA) and messenger RNA (mRNA), are susceptible to degradation when exposed to the bodily fluids of humans, which can reduce stability and concentration. In this context, nanoscale delivery technologies are utilised. These agents offer encouraging prospects for the preservation and regulation of pharmaceutical substances, in addition to improving the solubility and stability of medications. Nanocarrier-based systems possess the notable advantage of facilitating accurate and sustained drug release, as opposed to traditional systemic methodologies. The primary focus of scientific investigation has been to augment the therapeutic efficacy of nanoparticles composed of lipids. Numerous nanoscale drug delivery techniques have been implemented to treat various respiratory ailments, such as lung cancer. These technologies have exhibited the potential to mitigate the limitations associated with conventional therapy. As an illustration, applying nanocarriers may enhance the solubility of small-molecule anticancer drugs and prevent the degradation of bio-macromolecular drugs. Furthermore, these devices can administer medications in a controlled and extended fashion, thereby augmenting the therapeutic intervention's effectiveness and reducing adverse reactions. However, despite these promising results, challenges remain that must be addressed. Multiple factors necessitate consideration when contemplating the application of nanoparticles in medical interventions. To begin with, the advancement of more efficient delivery methods is imperative. In addition, a comprehensive investigation into the potential toxicity of nanoparticles is required. Finally, additional research is needed to comprehend these treatments' enduring ramifications. Despite these challenges, the field of nanomedicine demonstrates considerable promise in enhancing the therapy of lung cancer and other respiratory diseases.

Bioengineered Abiotic Nanomaterials Through Cell Membrane-Camouflaging: Advancements and Challenges in Lung Cancer

Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics

Nanoengineered Polymers and Other Organic Materials in Lung Cancer Treatment: Bridging the Gap Between Research and Clinical Applications

Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.

Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment

Cell membrane-coated nanomaterials for cancer therapy

Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications

Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers

Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy

Cell Membrane-Camouflaged Nanoparticles as Drug Carriers for Cancer Therapy

Nanotechnology and Nanomedicine: A Promising Avenue for Lung Cancer Diagnosis and Therapy

Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles

Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy

Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy

Moving beyond traditional therapies: the role of nanomedicines in lung cancer

Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm

Nanomaterial-based cancer immunotherapy: enhancing treatment strategies

Research update on cell membrane camouflaged nanoparticles for cancer therapy

Bioengineering nanomaterials for tumor therapy and anti-metastasis

Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges

Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy